Nexus Letter for GERD Secondary to Medication: Evidence and Mechanism (2026)

Secondary Service Connection Through Medication

The VA recognizes that a service-connected disability can produce a secondary disability either directly (through the underlying pathophysiology) or indirectly through the treatment required for the primary condition. When a medication prescribed for a service-connected disability causes a new and separately diagnosable condition, that new condition can be claimed as secondary to the primary disability.

This medication-mediated pathway is particularly common for GERD because so many of the drug classes used long-term for chronic service-connected conditions have known gastrointestinal side effects. The mechanism is biological — the medication directly causes or worsens reflux through specific pharmacologic effects on the gastrointestinal system.

NSAIDs and GERD

Nonsteroidal anti-inflammatory drugs are among the most widely prescribed medications for service-connected musculoskeletal conditions, including back pain, knee and hip arthritis, and other chronic pain conditions. NSAIDs are a leading cause of medication-induced gastroesophageal and gastrointestinal pathology.

Mechanism

NSAIDs inhibit cyclooxygenase enzymes (COX-1 and COX-2). COX-1 inhibition reduces production of prostaglandins that protect the gastric and esophageal mucosa, increasing susceptibility to acid-related injury. NSAIDs also relax the lower esophageal sphincter and slow gastric emptying.

Common Drugs

Ibuprofen (Motrin, Advil), naproxen (Naprosyn, Aleve), diclofenac (Voltaren), meloxicam (Mobic), celecoxib (Celebrex), and ketorolac (Toradol) are commonly prescribed. Even over-the-counter NSAID use can produce significant esophageal and gastric pathology when used chronically.

Clinical Manifestations

NSAID-induced GERD presents with heartburn, regurgitation, dysphagia, chest pain, and in severe cases erosive esophagitis or strictures visible on endoscopy. Co-administration with proton pump inhibitors does not eliminate the risk.

Oral Corticosteroids

Oral corticosteroids are prescribed for service-connected conditions such as autoimmune disorders, severe inflammatory conditions, asthma exacerbations, and some musculoskeletal conditions. Common medications include prednisone, methylprednisolone, dexamethasone, and hydrocortisone.

Mechanism

Corticosteroids increase gastric acid secretion, decrease prostaglandin-mediated mucosal protection, and slow ulcer healing. The risk is amplified when corticosteroids are co-administered with NSAIDs.

Clinical Implications

Veterans on chronic corticosteroid therapy frequently require concurrent prophylactic acid-suppressing medication. The development of GERD or peptic ulcer disease in this setting is a recognized adverse effect of the steroid therapy.

Opioid Analgesics

Opioids are commonly prescribed for chronic pain conditions including back pain, post-surgical pain, and severe musculoskeletal disability. Common medications include hydrocodone, oxycodone, morphine, fentanyl, tramadol, and methadone.

Mechanism

Opioids slow gastric emptying and decrease lower esophageal sphincter tone, both of which promote acid reflux. Opioid-induced bowel dysfunction further contributes to upper gastrointestinal symptoms.

Symptom Pattern

Veterans on chronic opioid therapy frequently report new or worsened heartburn, nausea, regurgitation, and bloating. The symptoms typically improve when opioid doses are reduced and worsen when doses are increased — a pattern that supports the medication-induced etiology.

Antihypertensives, Nitrates, and Calcium Channel Blockers

Several cardiovascular medications prescribed for service-connected hypertension or other cardiac conditions can promote reflux.

Calcium Channel Blockers

Amlodipine, nifedipine, and diltiazem reduce smooth muscle tone, including the lower esophageal sphincter, which facilitates reflux of gastric contents into the esophagus.

Nitrates

Nitroglycerin, isosorbide mononitrate, and isosorbide dinitrate produce smooth muscle relaxation throughout the body, including the lower esophageal sphincter.

Anticholinergics

Medications with anticholinergic properties — used for various conditions — slow gastric emptying and reduce lower esophageal sphincter tone.

Antidepressants and Anxiolytics

Veterans with service-connected mental health conditions frequently take antidepressants or anxiolytics that have GI side effects.

Tricyclic Antidepressants

Amitriptyline, nortriptyline, and imipramine have anticholinergic effects that slow gastric emptying and reduce lower esophageal sphincter tone.

Selective Serotonin Reuptake Inhibitors (SSRIs)

Sertraline, fluoxetine, paroxetine, and citalopram can cause GI side effects including dyspepsia and reflux through serotonergic effects on gut motility.

Benzodiazepines

Long-term benzodiazepine use can decrease lower esophageal sphincter pressure and contribute to reflux symptoms.

Bisphosphonates

Oral bisphosphonates such as alendronate (Fosamax), risedronate (Actonel), and ibandronate (Boniva) — sometimes prescribed for osteoporosis associated with service-connected conditions or long-term steroid use — are well-known causes of esophageal irritation, esophagitis, and GERD. The medication can directly damage the esophageal mucosa when not taken with adequate water and upright posture.

GERD Diagnosis and Rating Under DC 7346

GERD is rated under 38 CFR 4.114, Diagnostic Code 7346 (hiatal hernia/gastroesophageal reflux), based on the severity of symptoms and the impact on overall health.

60 Percent

Symptoms of pain, vomiting, material weight loss, and hematemesis or melena with moderate anemia, or other symptom combinations productive of severe impairment of health.

30 Percent

Persistently recurrent epigastric distress with dysphagia, pyrosis, and regurgitation, accompanied by substernal or arm or shoulder pain, productive of considerable impairment of health.

10 Percent

Two or more of the symptoms required for the 30 percent rating but of less severity.

0 Percent

Symptoms not meeting the 10 percent criteria.

Diagnostic confirmation of GERD typically rests on clinical history, response to acid-suppressing medication, and where indicated, endoscopy with biopsy, esophageal manometry, or 24-hour pH monitoring.

Building a Strong Nexus Letter

A defensible nexus letter for GERD secondary to medication contains the following elements.

Identification of the Service-Connected Condition

The letter should reference the existing service-connected disability for which the medication is prescribed — for example, "service-connected lumbar degenerative disc disease, currently rated at 40 percent."

Documentation of the Medication Regimen

The specific medication, dose, frequency, and duration should be documented. The letter should reference the prescribing records, pharmacy records, or VA medication list.

Current GERD Diagnosis

The current diagnosis of GERD should be supported by clinical history, treatment records, and any relevant diagnostic studies (endoscopy, pH monitoring).

Temporal Relationship

The letter should describe when GERD symptoms began relative to medication initiation. A clear temporal relationship — symptom onset after medication initiation, worsening with dose escalation, partial improvement with dose reduction — strongly supports the connection.

Pharmacologic Mechanism

The letter should articulate the specific pharmacologic mechanism by which the medication causes or worsens GERD — for example, "NSAIDs inhibit COX-1 mediated prostaglandin synthesis, reducing the protective mucosal barrier of the gastric and esophageal lining and increasing susceptibility to acid-related injury."

"At Least as Likely as Not" Language

The opinion must use the VA's required threshold — that the GERD is at least as likely as not (50 percent or greater probability) caused or aggravated by the medication prescribed for the service-connected condition.

Records-Based Review

The letter should affirm that the physician reviewed the service treatment records, post-service medical records, prescribing history, and any diagnostic studies before forming the opinion.